Federal Circuit Orders Court To Hear Vitamin Suit

Law360, New York (April 7, 2006, 12:00 AM EDT) -- In a setback for Metabolite Laboratories Inc., the U.S. Court of Appeals for the Federal Circuit sided Friday with a generic drug maker, ruling that its preemptive lawsuit over generic vitamins should not have been dismissed by a Florida district court.

In the appeal by Breckenridge Pharmaceutical Inc., the Federal Circuit ruled that the U.S. District Court for the Southern District of Florida erred in dismissing the case over lack of personal jurisdiction over defendant Metabolite.

The Federal Circuit also ruled the district court incorrectly granted...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.